T
Talkmed Group Ltd
SGX:5G3
Talkmed Group Ltd
SGX:5G3
Price:
0.455
SGD
Market Closed
Market Cap:
S$609m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Talkmed Group Ltd
SGX:5G3
|
SG |
|
A
|
Armada Metals Ltd
ASX:AMM
|
AU |
|
Easun Reyrolle Ltd
NSE:EASUNREYRL
|
IN |
|
X
|
Xpeng Inc
HKEX:9868
|
CN |
|
Xingda International Holdings Ltd
HKEX:1899
|
CN |
|
Air Lease Corp
NYSE:AL
|
US |
|
Yutong Heavy Industries Co Ltd
SSE:600817
|
CN |
|
V
|
Virgin Wines UK PLC
LSE:VINO
|
UK |
|
CyberPower Systems Inc
TWSE:3617
|
TW |
|
S
|
SWS Hemodialysis Care Co Ltd
SSE:688410
|
CN |
|
R
|
Rovsing A/S
CSE:ROV
|
DK |
|
Orion Minerals Ltd
ASX:ORN
|
AU |
|
M
|
Minshang Creative Technology Holdings Ltd
HKEX:1632
|
HK |
|
W
|
Wheaton Precious Metals Corp
NYSE:WPM
|
CA |
|
C
|
Chakana Copper Corp
SWB:1ZX
|
CA |
|
Alpha Group
SZSE:002292
|
CN |
Multiples-Based Value
The Multiples-Based Value for Talkmed Group Ltd (5G3) under the Base Case is hidden SGD. Compared with the current market price of 0.455 SGD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
5G3 Multiples-Based Value
LOCKED
Multiples Across Competitors
5G3 Competitors Multiples
Talkmed Group Ltd Competitors
Talkmed Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SG |
T
|
Talkmed Group Ltd
SGX:5G3
|
604.8m SGD | 7.7 | 13.8 | 15 | 16.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
93.4B USD | 0.2 | 53 | 13.7 | 13.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.2B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
71.1B USD | 0.3 | 12.1 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.5B EUR | 1.1 | 19.4 | 9.2 | 13.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.5B EUR | 1.1 | 23 | 8.9 | 16.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 1.6 | 25.6 | 12.3 | 17.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 2 | 22 | 11.9 | 16.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.6 | 11 | 5.3 | 9.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.3B USD | 12.1 | -28.5 | -31.2 | -28.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD | 0.7 | 13.6 | 7.1 | 9.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
